Woodline Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Woodline Partners's ELV Position: Q1 2026 in Review
Woodline Partners increased its Elevance Health (ELV) stake by 571% in Q1 2026, buying an estimated $6.62M and bringing the position to 23,653 shares worth $6.92M. The position accounts for 0.03% of the portfolio, ranked #596.
Woodline Partners first reported a position in ELV in Q1 2020 and has held it in 7 quarters since. The position peaked at $57M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Woodline Partners held 23,653 shares of Elevance Health worth $6.92M as of Q1 2026.
- Woodline Partners bought 20,130 Elevance Health shares in Q1 2026, an estimated $6.62M.
- Elevance Health made up 0.03% of Woodline Partners's portfolio in Q1 2026, its #596 holding.
- Woodline Partners first reported a position in Elevance Health in Q1 2020 and has held it in 7 quarters since.
- Woodline Partners's Elevance Health position peaked at $57M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.